The WACC of Nektar Therapeutics (NKTR) is 7.8%.
| Range | Selected | |
| Cost of equity | 6.70% - 14.70% | 10.70% |
| Tax rate | 0.10% - 0.10% | 0.10% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.8% - 9.9% | 7.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.61 | 1.76 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.70% | 14.70% |
| Tax rate | 0.10% | 0.10% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.8% | 9.9% |
| Selected WACC | 7.8% | |